Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Oncological treatment and outcome of colorectal cancer in Greenland

Research output: Contribution to journalJournal articleResearchpeer-review

  1. No association between early maternal HbA1c and offspring birthweight among women without pre-existing diabetes in Greenland

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Diabetes in Greenland - how to deliver diabetes care in a country with a geographically dispersed population

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Gestational diabetes and macrosomia among Greenlanders. Time to change diagnostic strategy?

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Gonorrhoea in Greenland: geographic differences in diagnostic activity and incidence of gonorrhoea in 2015

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Regional variation in out-of-hospital cardiac arrest: incidence and survival - a nationwide study of regions in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The clinical use of hyperbaric oxygen in the treatment of Danish patients with diabetic foot ulcers

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Short-stay unit hospitalisation vs. standard care outcomes in older internal medicine patients-a randomised clinical trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Endoscopic electrochemotherapy for esophageal cancer: a phase I clinical study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Oncological treatment of colorectal cancer (CRC) has been available in Greenland since 2004. Treatment is provided by Queen Ingrid´s Hospital (QIH), under supervision from the Department of Oncology, Rigshospitalet, Denmark. The study describes patient characteristics, oncological treatment and survival for the first 8 years of treatment. The study was a registry-based observational study of all patients in Greenland diagnosed with histologically verified CRC from August 2004 to August 2012. Analyses were stratified according to stage and discussed in relation to reported data from patients with CRC in Denmark. 180 patients were included. . Stage I, II, III, and IV comprised 15, 34, 23, and 23%, respectively. 5% presented with unknown stage. A total of 51% received oncological treatment. 79% of patients with Stage III disease received adjuvant chemotherapy, 61% of patients with metastatic CRC received palliative chemotherapy. Five-year survival was 48 and 53% for colon and rectum cancer, respectively. An insignificant trend towards higher survival in men than in women was seen; adjusted hazard ratio for death (women vs men) = 1.46 (95% CI = 0.97-2.19). In conclusion; Stage distribution, provision of oncological treatment and 5-year survival were comparable to patients diagnosed and treated in Denmark.

Original languageEnglish
JournalInternational Journal of Circumpolar Health
Volume77
Issue number1
Pages (from-to)1546069
ISSN1239-9736
DOIs
Publication statusPublished - 2018

ID: 55670832